Highlights from the European Parliament meeting ‘Ensuring equitable access to high-quality treatment in brain, mind and pain disorders – Case-Studies from across Europe’ on 22 November, 2017.
A meeting of the Members of the European Parliament… Continue Reading 
by Anna Sauerbier
The societal impact of pain (SIP) 2017 Steering Committee Meeting
New techniques target protein clumps linked to Alzheimer’s and cancer
Inside the solitary life of an Alzheimer’s sufferer
E-health Tallinn 2017: i-prognosis… Continue Reading 
Following the Board Meeting and General Assembly of the Alliance for Biomedical Research in Europe that took place on November 8, please find attached the Alliance’s joint statement with FEAM – Federation of European Academies of Medicine related to… Continue Reading
by Anna Sauerbier
EMA’s support to Multiple Sclerosis Registry initiative
by Anna Sauerbier
September is World Alzheimer’s Month
By Anna Sauerbier
Can a diabetes drug be repurposed to treat Parkinson’s too?
http://parkinsonslife.eu/can-diabetes-drug-repurposed-treat-parkinsons/
The ParkinsonNet programme
http://parkinsonslife.eu/parkinsonnet-starbucks-formula-new-approach-parkinsons-treatment-bas-bloem/
Scientists discover how the brain’s hypothalamus controls ageing – and manage to slow it down
https://theconversation.com/scientists-discover-how-the-brains-hypothalamus-controls-ageing-and-manage-to-slow-it-down-81510… Continue Reading 
by Anna Sauerbier
Neuroscience-based Nomenclature